Immune to addiction: the ethical dimensions of vaccines against substance abuse

Journal name:
Nature Immunology
Volume:
13,
Pages:
521–524
Year published:
DOI:
doi:10.1038/ni.2321
Published online

Abstract

Promising advances have been made in recent years for a unique class of immunotherapies that use vaccination to combat substance-use disorders. Although such vaccines are potentially useful for addictions, they raise a variety of ethical and social questions.

References

  1. Orson, F.M. et al. Ann. NY Acad. Sci. 1141, 257269 (2008).
  2. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration, “Drug Abuse Warning Network, 2009: National Estimates of Drug-Related Emergency Department Visits.” HHS Publication (SMA) 11-4659, DAWN Series D-35 (Substance Abuse and Mental Health Services Administration, Rockville, Maryland, 2011).
  3. Volkow, N.D. & Skolnick, P. Neuropsychopharmacology 37, 290292 (2012).
  4. O'Brien, M.S. & Anthony, J.C. Neuropsychopharmacology 30, 10061018 (2005).
  5. Haney, M., Gunderson, E.W., Jiang, H., Collins, E.D. & Foltin, R.W. Biol. Psychiatry 67, 5965 (2010).
  6. Martell, B.A. et al. Arch. Gen. Psychiatry 66, 11161123 (2009).
  7. Carrera, M.R. et al. Nature 378, 727730 (1995).
  8. Stevenson, D. Rutgers J. L. & Urb. Pol'y 3, 4, n.170 (2005).
  9. Ersche, K.D. et al. Science 335, 601604 (2012).
  10. Hyman, S.E. Am. J. Bioeth. 7, 811 (2007).
  11. Osburn, A. Cleveland State Law Rev. 55, 159188 (2008).
  12. Ashcroft, R.E. & Franey, C. J. Med. Ethics 30, 341343 (2004).
  13. Friedman, H., Pross, S. & Klein, T.W. Fems. Immunol. Med. Microbiol. 47, 330342 (2006).
  14. Christakis, N.A. & Fowler, J.H. Connected: The Surprising Power of Our Social Networks and How They Shape Our Lives, 1st edn. (Little, Brown and Co./Hachette Book Group, New York, 2009).
  15. Caplan, A. Addiction 103, 19191921 (2008).
  16. Yaffe, G. Philos. Public Aff. 30, 178221 (2001).
  17. Hall, W. & Carter, L. J. Med. Ethics 30, 337340 (2004).
  18. Hasman, A. & Holm, S. J. Med. Ethics 30, 344345 (2004).
  19. Caplan, A. in Human Enhancement (eds. Savelescu, J. & Bostrum, N.) 199210 (Oxford University Press, Oxford, 2009).
  20. Newman, P.A., Daley, A., Halpenny, R. & Loutfy, M. Vaccine 26, 10911097 (2008).
  21. Newman, P.A., Duan, N., Kakinami, L. & Roberts, K. Vaccine 26, 25282536 (2008).
  22. Kosten, T. & Owens, S.M. Pharmacol. Ther. 108, 7685 (2005).
  23. Kosten, T.R. et al. Vaccine 20, 11961204 (2002).
  24. Buka, S.L. Public Health Rep. 117, S118S125 (2002).
  25. Francis, A. Sociol. Health. Illn. 20, 116 (2012).

Download references

Author information

Affiliations

  1. Michael J. Young is in the Faculty of Philosophy, University of Cambridge, Cambridge, UK.

  2. Dominic A. Sisti and Hila Rimon-Greenspan are with The Scattergood Program for the Applied Ethics of Behavioral Healthcare, Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

  3. Jason L. Schwartz is in the Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

  4. Arthur L. Caplan is with the Division of Medical Ethics, NYU Langone Medical Center, New York, New York, USA.

Competing financial interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to:

Author details

Additional data